MarketCap
Facebook
X
TelegramItamar Medical Ltd. Betriebsaufwand 2011-2026 | ITMR
Betriebsaufwand Jährlich Itamar Medical Ltd.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 39.1 M | 29.2 M | 21.6 M | 21.5 M | 23.5 M | 17.9 M | 15.2 M | 14.3 M | 10.1 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 39.1 M | 10.1 M | 21.4 M |
Betriebsaufwand anderer Aktien in der Medizinische Geräte
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B |  USA |
 |
Sensus Healthcare
SRTS
|
22.2 M | $ 4.1 | -2.96 % | $ 66.9 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 9.86 | 3.25 % | $ 759 M | USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 9.18 | -0.22 % | $ 329 M | USA |
 |
Stryker Corporation
SYK
|
11.2 B | $ 335.31 | 2.37 % | $ 128 B | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
TELA Bio
TELA
|
88.1 M | $ 0.71 | 3.13 % | $ 33.3 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 36.91 | -0.32 % | $ 1.15 B | USA |
 |
Insulet Corporation
PODD
|
531 M | $ 220.63 | 2.14 % | $ 15.5 B | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Tandem Diabetes Care
TNDM
|
159 M | $ 23.46 | -3.32 % | $ 1.6 B | USA |
 |
Electromed
ELMD
|
40.3 M | $ 24.74 | 0.32 % | $ 209 M | USA |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.62 | -8.39 % | $ 33.7 M | USA |
 |
Aethlon Medical
AEMD
|
9.34 M | $ 2.37 | 2.22 % | $ 3.7 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Smith & Nephew plc
SNN
|
2.67 B | $ 32.45 | - | $ 23.8 B |  Britain |
 |
LivaNova PLC
LIVN
|
697 M | $ 64.75 | 2.28 % | $ 3.53 B | Britain |
 |
InspireMD
NSPR
|
52.3 M | $ 1.74 | -0.57 % | $ 112 M |  Israel |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 11.6 | 1.84 % | $ 1.57 B | USA |
 |
Penumbra
PEN
|
753 M | $ 337.13 | 0.26 % | $ 13.1 B | USA |
 |
MiMedx Group
MDXG
|
277 M | $ 4.08 | -0.49 % | $ 603 M | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
Viemed Healthcare
VMD
|
55.7 M | $ 9.32 | -0.32 % | $ 363 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.69 | -1.61 % | $ 28.9 M | USA |
 |
NanoVibronix
NAOV
|
5.09 M | - | - | $ 1.08 M | USA |
 |
Varex Imaging Corporation
VREX
|
318 M | $ 10.72 | 0.28 % | $ 444 M | USA |
 |
Vivos Therapeutics
VVOS
|
20.2 M | $ 1.24 | 7.37 % | $ 6.22 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 51.41 | - | $ 1.51 B | USA |
 |
Pulmonx Corporation
LUNG
|
121 M | $ 1.29 | -1.15 % | $ 52.5 M | USA |
 |
Beyond Air
XAIR
|
42.9 M | $ 0.74 | 0.01 % | $ 50.1 M | USA |
 |
Xtant Medical Holdings
XTNT
|
80.3 M | $ 0.57 | 0.85 % | $ 76.2 M | USA |